Call us:

Data-Independent Acquisition (DIA) Proteomics

Accuracy: High-resolution mass spectrometry for precise results.
Stability: 1 ppm accuracy over time, minimal corrections.
Sensitivity: Detects low-abundance proteins (amol levels).
Efficiency: Monitors all proteins at once, faster analysis.
Speed: Rapid 12-20 Hz scanning.
Range: Wide dynamic range for comprehensive quantification.
Selectivity: Enhanced with msxDIA technology.

Reliable Identification: dia-PASEF enhances sensitivity and selectivity.
Speedier Analysis: TIMS separation accelerates while maintaining accuracy.
Comprehensive Coverage: Deeper insights with extensive proteome coverage.
High-Sensitivity Targeting: prm-PASEF boosts target monitoring without compromise.

Proteomics in Therapeutic Areas

At creative proteomics, our mission is to accelerate the progress for disease research projects with our unparalleled analytical technology and advanced omics technology platform, to make outstanding contributions to disease diagnosis, treatment, and prognosis. This is why we are trusted by the world's leading biopharmaceutical companies and research institutions to advance their drug discovery, preclinical and clinical research projects. We have extensive experience in oncology, immunology and immune-mediated inflammatory diseases. Make full use of the infinite possibilities of scientific innovation and more than 50 diseases can be detected in one platform.

Oncology

Accelerate your oncology program using our comprehensive suite of quantitative proteomics services for large cohort clinical samples.

Inflammatory Diseases

Advance inflammatory diseases research with our integrated quantitative proteomics for Alzheimer's disease, Parkinson's, Autism, Chronic pain, etc.

Neurological Disorders

Discover of unique high throughput quantitative proteomics platform for Neurological disorders enables large-scale proteomic or phosphoproteomic analysis of brain tissue or cerebrospinal fluid.

Metabolic Diseases

Next-generation proteomics has increasing use in endocrine and metabolic diseases, including pituitary, thyroid, bone metabolic disorders, diabetes, and obesity.

Rare Disease

Reveal a deeper understanding of the underlying biology and provide actionable knowledge to accelerate and de-risk your research in rare diseases.

* For Research Use Only. Not for use in the treatment or diagnosis of disease.

ICON 4D Proteomics with Data-Independent Acquisition (DIA)

50% detection rate of low-peak intensity proteins
Higher integrity and reproducibility of protein data
Nearly 100% ion utilization, greatly improving detection sensitivity
Fewer injections, shorter gradients, and deeper coverage
Stronger support for PTM identification

Specializing in proteomics, Creative Proteomics offers cutting-edge protein analysis services. Our distinctive approach revolves around harnessing the power of DIA technology, enabling us to deliver precise and comprehensive insights that drive advancements in research and industry.

USA
Tel:
Fax:
Email:
Germany